Stéphane Bancel, Moderna CEO (Photo by Michael Brochstein/Sipa USA)(Sipa via AP Images)
November 7, 2024 06:30 AM ESTUpdated 06:48 AM
People
Pharma

Mod­er­na re­ports slow start to RSV sales as Ban­cel steps back from com­mer­cial role

Max Bayer

Pharma Reporter

Mod­er­na re­vealed the con­se­quences of its late start in the mar­ket for RSV vac­cines, re­port­ing just $10 mil­lion in third-quar­ter sales from the new shot …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times